Literature DB >> 12353364

Conflict of interest from a Romanian geneticist's perspective.

Ioana Ispas1.   

Abstract

This paper examines Romanian bioethics regulations for biomedical sciences, looking in particular at the genetics area as a source for conflict of interest. The analysis is focused on the organizational level, national regulations, the sources for generating conflicts of interest, and management of conflicts. Modern biotechnology and gene technology are among the key technologies of the twenty-first century. The application of gene technology for medical and pharmaceutical purposes is widely accepted by society, but the same cannot be said of the development and application of gene technology in agriculture and food processing. Because the use of a technology in the production and processing of food is regarded more sceptically than in the production of biomedical products, there can be areas of conflict in many cases when communication is undertaken about gene technology in the agro-food sector. Ethical concerns play an important factor in this, but a society's attitude to a developing technology is an amalgam of many effects which are beyond ethics as such. This paper contains a study carried out by the author for the Romanian Association for Consumer Protection about the attitudes of consumers towards genetically modified (GM) foods. This study revealed that in Romania more than 98% of consumers did not know anything about GM foods and frequently were confused about the definitions of these terms. In conclusion, it is necessary to say that there is a low level of knowledge regarding biotechnology in Romania and this is an important reason why there is neither public acceptance of gene technology products nor is there a rejection.

Entities:  

Keywords:  Bioethics and Professional Ethics; Genetics and Reproduction

Mesh:

Year:  2002        PMID: 12353364     DOI: 10.1007/s11948-002-0056-8

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  1 in total

1.  Beyond 'substantial equivalence'.

Authors:  E Millstone; E Brunner; S Mayer
Journal:  Nature       Date:  1999-10-07       Impact factor: 49.962

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.